Does Metformin (Glucophage) Lower Cancer Risk?
Filed Under (Cancer) by David on 15-12-2009
0
Metformin (Glucophage drugs , Bristol-Myers Squibb) may help protect against cancer. Researchers from the University of Dundee in the United Kingdom found a 37% reduced risk with metformin and say that their findings warrant a randomized trial. During 10 years of follow-up, cancer occurred in 297 of 4,085 patients (7.3%) new to using metformin, compared with 474 (11.6%) of 4,085 non-users.